Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension
| Autor: | Janis M. Dionne, Shelagh B. Coutts, Donna McLean, Mark Gelfer, Michel Vallée, Sheldon W. Tobe, Kara Nerenberg, Debra Reid, Milan Khara, Raj Padwal, Kaberi Dasgupta, Pierre Larochelle, Robert A. Hegele, Marcel Lebel, Vincent Woo, Peter Bolli, Patrice Lindsay, Gregory Moullec, Luc Trudeau, Gord Gubitz, Michael D. Hill, Robert J. Herman, Alexander G. Logan, Lyne Cloutier, Maxime Lamarre-Cliche, Philip A. McFarlane, Kim L. Lavoie, Charlotte Jones, Richard E. Gilbert, Janusz Kaczorowski, Steven A. Grover, Geneviève Benoit, Alain Milot, Ally P.H. Prebtani, Lawrence A. Leiter, G. V. Ramesh Prasad, George K. Dresser, Andrew L. Pipe, Milan Gupta, Swapnil Hiremath, George Fodor, Tavis S. Campbell, Kevin D. Burns, Simon W. Rabkin, Peter Selby, Stella S. Daskalopoulou, Alexander A. Leung, Norman R.C. Campbell, Simon L. Bacon, Richard I. Ogilvie, Thomas W. Wilson, Marcel Ruzicka, Ellen Burgess, Robert J. Petrella, Gordon W. Moe, Anne Fournier, Kevin C. Harris, George Honos, Kelly B. Zarnke, Paul Oh, Janusz Feber, Kerry McBrien, Laura A. Magee, Jean Grégoire, S. Brian Penner, Luc Poirier, Ernesto L. Schiffrin, Mukul Sharma, Jonathan G. Howlett, Doreen M. Rabi, Ross D. Feldman, Jean-Martin Boulanger, Pavel Hamet, Richard Lewanczuk, Denis Drouin, Guy Tremblay, Scott A. Lear |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Canada Hyperkalemia medicine.drug_class Secondary hypertension Calcium channel blocker 030204 cardiovascular system & hematology Risk Assessment 03 medical and health sciences 0302 clinical medicine Risk Factors Hyperaldosteronism medicine Humans 030212 general & internal medicine Intensive care medicine Health Education Antihypertensive Agents Evidence-Based Medicine business.industry Blood Pressure Determination Guideline Evidence-based medicine medicine.disease Blood pressure Hypertension medicine.symptom Cardiology and Cardiovascular Medicine Risk assessment business |
| Zdroj: | The Canadian journal of cardiology. 32(5) |
| ISSN: | 1916-7075 |
| Popis: | Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force provides annually updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present 4 new recommendations, as well as revisions to 2 previous recommendations. In the diagnosis and assessment of hypertension, automated office blood pressure, taken without patient-health provider interaction, is now recommended as the preferred method of measuring in-office blood pressure. Also, although a serum lipid panel remains part of the routine laboratory testing for patients with hypertension, fasting and nonfasting collections are now considered acceptable. For individuals with secondary hypertension arising from primary hyperaldosteronism, adrenal vein sampling is recommended for those who are candidates for potential adrenalectomy. With respect to the treatment of hypertension, a new recommendation that has been added is for increasing dietary potassium to reduce blood pressure in those who are not at high risk for hyperkalemia. Furthermore, in selected high-risk patients, intensive blood pressure reduction to a target systolic blood pressure ≤ 120 mm Hg should be considered to decrease the risk of cardiovascular events. Finally, in hypertensive individuals with uncomplicated, stable angina pectoris, either a β-blocker or calcium channel blocker may be considered for initial therapy. The specific evidence and rationale underlying each of these recommendations are discussed. Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force will continue to provide annual updates. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect